Skip to content

Mitochondrial Dna Depletion Syndrome 4b C3150914

Published: July 22, 2026Updated: August 20, 2026

A genetic mitochondrial disease causing progressive organ damage from cellular energy failure, often affecting muscles and nerves. Treatment aims to manage symptoms and support organ function.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
G40.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Seizures

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Myopathy with muscle weakness

(neurologic)

Encephalopathy with cognitive decline

(neurologic)

Peripheral neuropathy causing sensory deficits

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Drug therapy with clinical monitoring

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Specialized Hepatic Diet

Nutritional support tailored to hepatic function, including protein restriction if hepatic encephalopathy develops and supplementation with fat-soluble vitamins.

dietary
3

Hepatoprotective Agents

Use of compounds such as N-acetylcysteine and vitamin E to support liver function and reduce oxidative stress on hepatic mitochondria.

medication

Additional treatment options

Hepatic Function Surveillance

Frequent monitoring of liver enzymes, bilirubin, coagulation studies, and abdominal imaging to detect progression of hepatic involvement.

monitoring

Antioxidant Cocktail Therapy

Combination of antioxidants including alpha-lipoic acid, selenium, and Coenzyme Q10 to reduce oxidative damage to mitochondria and support cellular energy production.

medication

Milk Thistle Extract

Silymarin from milk thistle has hepatoprotective properties and may support liver mitochondrial function through antioxidant mechanisms.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Mitochondrial Dna Depletion Syndrome 4b C3150914?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Medication Comparisons

Compare medications used to treat Mitochondrial Dna Depletion Syndrome 4b C3150914. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy